Aim Dyslipidemia is an established marker for endothelial dysfunction and cardiovascular
risk in diabetes. So we aimed to explore the prevalence of dyslipidemia in patients with …

Cardiovascular disease (CVD) remains the main cause of morbidity and mortality in
individuals with type 1 diabetes (T1D). Adolescence appears to be a critical time for the …

Cardiovascular disease (CVD) is the leading cause of death in Type 1 Diabetes (T1D). The
molecular basis for atherosclerosis in T1D is heavily influenced by hyperglycaemia and its …

Background Lipoprotein disturbances have been associated with increased cardiovascular
disease (CVD) risk in type 1 diabetes mellitus (T1DM). We assessed the advanced …

Background Children with type 1 diabetes having dyslipidemia are at increased risk of
developing premature atherosclerosis and cardiovascular disease. The present study aims …

Background Dyslipidemias are disorders of lipoprotein metabolism that occur during
childhood and adolescence, often persist into adulthood, and increase the risk of developing …

Objectives The present study was conducted to determine the prevalence of dyslipidemia
among patients with type 1 diabetes mellitus (T1DM) and its associated factors in Saudi …

Aim To determine low‐density lipoprotein cholesterol (LDL‐C) screening frequency and
levels, and factors associated with elevated LDL‐C, in Australasian youth with type 1 …

Background The prevalence of immunoglobulin A nephropathy (IgAN) seems to be higher in
patients with type 1 diabetes mellitus (T1DM) than that in the general population. However …

Purpose ANGPTL8, commonly referred to as betatrophin, has demonstrated promise as a
dependable marker for the onset of complications associated with diabetes mellitus, such as …